An Insistent Push for Screening
When Etti Zohar, 45, insisted that she and her husband Lior, 49, undergo routine colonoscopies three years ago, neither anticipated that the decision would uncover a serious malignancy. The couple, residents of Hadera and parents to three daughters, pursued the screenings largely because two of their children had been diagnosed with Crohn’s disease at a young age, prompting Etti to investigate potential familial bowel conditions (Ynetnews). Although health funds initially declined the referrals due to their age under 50, Etti’s persistence eventually secured appointments.
The subsequent tests revealed a stark contrast in their initial results. While Etti’s examination was clear, physicians discovered a tennis-ball-sized tumor in Lior’s bowel. Lior reported experiencing no prior symptoms, leaving the couple stunned as they processed the unexpected diagnosis in the immediate aftermath of the medical procedure (Ynetnews).
A Second Diagnosis Within Weeks
The medical crisis escalated profoundly just weeks later while the family awaited Lior’s biopsy results. Etti discovered a small lump in her right breast, followed shortly by a swollen lymph node in her armpit. Subsequent imaging and examinations at a medical center confirmed an aggressive cancerous tumor (Ynetnews). The simultaneous occurrence of two severe cancer diagnoses within the same household plunged the family into intense emotional and logistical strain.
According to the couple, an online chatbot estimated the probability of both spouses being diagnosed with independent cancers in the exact same month at roughly one in hundreds of millions (Ynetnews). Despite the overwhelming nature of the dual diagnoses, the family chose to keep their struggles private from friends and extended relatives until formal biopsies and treatment plans were established.
Navigating Parallel Treatments and Severe Complications
Both spouses embarked on rigorous treatment regimens involving chemotherapy, radiation, and surgery. Lior enrolled in a clinical study for rectal cancer, while Etti began aggressive therapy at Beilinson Hospital, part of Rabin Medical Center (Ynetnews). The parallel schedules allowed them to share a deep, unspoken understanding of the physical toll, occasionally receiving chemotherapy side by side in adjacent treatment chairs.
However, Etti’s medical journey included a near-fatal setback when an innovative combination of chemotherapy and biologic therapy severely suppressed her immune system. Transferred to the emergency room and subsequently placed in isolation at Beilinson Hospital, she suffered from extreme dehydration and disorientation before oncologist Prof. Rinat Yerushalmi Misheli identified the root cause: Addison’s disease, triggered by the biologic medication (Ynetnews). The condition halted normal cortisol production, requiring ongoing hormone replacement therapy.
Recovery and Current Status
Following successful tumor removal surgeries, specialized therapies, and extended recovery periods, treatment concluded two years ago. Both Etti and Lior remain under active medical follow-up care (Ynetnews). The family credits their resilience, the support of extended relatives, and professional psychological guidance for their daughters with maintaining household stability through the ordeal.
Clinical Perspectives on Early Detection and Oncology Trials
Medical professionals emphasize that the Zohars’ trajectory underscores critical conversations surrounding screening protocols and emerging treatments. Prof. Baruch Brenner, head of the Oncology Department at the Davidoff Center at Beilinson Hospital and chief oncologist at Clalit Health Services, notes an alarming global rise in individuals diagnosed under the age of 50. While the primary risk factor remains genetic, lifestyle components such as processed foods, stress, and lack of physical activity heavily interact with underlying predispositions (Ynetnews). Lior’s participation in a pioneering study combining preoperative chemo-radiation with immunotherapy reflects ongoing efforts to refine rectal cancer interventions.
Similarly, Prof. Rinat Yerushalmi Misheli, head of the Breast Oncology Unit at the Davidoff Center, points out that approximately 12 percent of women in Israel develop breast cancer during their lifetimes. Beyond established genetic factors like BRCA mutations—which now include expanded national screening eligibility for women of Ethiopian descent alongside Ashkenazi populations—lifestyle factors and early or late hormonal milestones significantly influence risk profiles (Ynetnews). The family’s public sharing of their ordeal ultimately serves to highlight the life-saving potential of advocating for preventative medical screenings well before standard age thresholds.